Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

1

Settlement

1

Closed

0

Total Settlement

$30M

INOVIO PHARMACEUTICALS, INC. (INO) Class Action Lawsuit (February 2026)

In Litigation

2:26cv803 • February 6, 2026

Class Period Start

October 10, 2023

Class Period End

December 26, 2025

PSLRA Deadline

April 7, 2026

Case Allegations

10b5

Statutes of Repose

Oct 10, 2026

Country

United States

Court

Federal Court

Docket History

Sep 24, 2026

First Amended Complaint

A new complaint has been filed on behalf of certain investors in INOVIO PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jul 27, 2026

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Feb 6, 2026

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in INOVIO PHARMACEUTICALS, INC..

INOVIO PHARMACEUTICALS, INC. (INO) Class Action Lawsuit (March 2020)

Settlement

2:20cv1402 • March 12, 2020

Class Period Start

February 13, 2020

Class Period End

November 6, 2020

PSLRA Deadline

May 12, 2020

Case Allegations

10b5

Statutes of Repose

Feb 13, 2023

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

December 19, 2022

Settlement Fund

$30,000,000

Settlement Status

Final Approval

Settlement Class

All persons or entities that purchased or otherwise acquired the common stock of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) from February 14, 2020 through August 10, 2020, inclusive.

Claim Administrator

Gilardi & Co. LLC
Inovio Securities Litigation Claims Administrator c/o Gilardi & Co. LLC P.O. Box 6162 Novato, CA 94948-6162
+1 866-809-3338
[email protected]

Hearing Date

December 15, 2022

Opt-out Deadline

November 23, 2022

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Feb 1, 2023

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Aug 31, 2022

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Aug 31, 2022

Class Certification Denied

The court has denied the request to proceed as a class action. This means the case cannot move forward on behalf of the proposed group of investors unless that decision changes or the court later approves a revised request.

Aug 31, 2022

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Aug 22, 2022

Proposed Settlement

View all Updates

TOP